Ariad Pharmaceuticals, Inc.

NASDAQ: ARIA
$23.99
+$0.00 (+0.0%)
Closing price February 17, 2017
Source: ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech...
Source: ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have already...
Source: ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The...
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Thursday, March 28, 2013. They include Lululemon, Nike, Under Armour and United Technologies.
Source: ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only to heart disease,...
Source: ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look...
Source: Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming...
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday.Advanced Micro Devices Inc. (NYSE: AMD) raised to Neutral from Sell...
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday.Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) Maintained Hold at...
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  The 2012 annual meeting of the American...
The biotech sector has seen its share of ups and downs in 2011 and prior years.  It is almost always the case that some of the top performing stocks each year come from this sector due to the...
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is raising cash to help support the commercialization of ponatinib in patients with resistant or intolerant CML and additional clinical development of its...
We have compiled a detailed list of expected upside in the biotech sector.  The sector has consolidated and now there is about to be a rush of earnings reports from tomorrow’s emerging drug...
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls.Amgen Inc. (NASDAQ: AMGN) Started as Outperform at BMO....